Capsular nevus versus metastatic malignant melanoma – a diagnostic dilemma

International Journal of Surgery Case Reports

Volumn 29, Issue , 2016, Pages 20-24

  Davis, Justin ^a   Patil, Jeevitha ^b   Aydin, Nail ^a   Mishra, Aparajita ^a   Misra, Subhasis ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; MELAN A; PROTEIN S 100;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CANCER DIAGNOSIS; CAPSULAR NEVUS; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTATIC MELANOMA; MIDDLE AGED; MITOSIS INDEX; NEVUS; NEVUS CELL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; SKINFOLD THICKNESS; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR VOLUME; WIDE EXCISION;

EID: 84994010400     PISSN: 22102612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijscr.2016.10.040     Document Type: Article

References (15)

1. [1] Piris, A., Mihm, M.C., Duncan, L.M., AJCC melanoma staging update: impact on dermatopathology practice and patient management. J. Cutan. Pathol. 38:5 (2011), 394–400.
2. [2] Ulmer, A., Dietz, K., Hodak, I., et al. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival. PLoS Med., 11(2), 2014, e1001604.
3. [3] Holt, J.B., Sangueza, O.P., Levine, E.A., et al. Nodal melanocytic nevi in sentinel lymph nodes correlation with melanoma-Associated cutaneous nevi. Am. J. Clin. Pathol. 121:1 (2004), 58–63.
4. [4] Lee, J.J., Granter, S.R., Laga, A.C., et al. 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod. Pathol., 2014.
5. [5] Biddle, D.A., Evans, H.L., Kemp, B.L., et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am. J. Surg. Pathol. 27:5 (2003), 673–681.
6. [6] Lohmann, C.M., Iversen, K., Jungbluth, A.A., Berwick, M., Busam, K.J., Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am. J. Surg. Pathol. 26:10 (2002), 1351–1357.
7. [7] Gambichler, T., Scholl, L., Stücker, M., et al. Clinical characteristics and survival data of melanoma patients with nevus cell aggregates within sentinel lymph nodes. Am. J. Clin. Pathol. 139:5 (2013), 566–573.
8. [8] Bowles, T.L., Xing, Y., Hu, C.-Y., et al. Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann. Surg. Oncol. 17:8 (2010), 2015–2023.
9. [9] Scolyer, R.A., Murali, R., McCarthy, S.W., Thompson, J.F., Histologically ambiguous (borderline) primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Arch. Pathol. Lab. Med. 134:12 (2010), 1770–1777.
10. [10] Gaiser, T., Kutzner, H., Palmedo, G., et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod. Pathol. 23:3 (2010), 413–419.
11. [11] Agha, R.A., Fowler, A.J., Saetta, A., Barai, I., Rajmohan, S., Orgill, D.P., for the SCARE Group, The SCARE statement: consensus-based surgical case report guidelines. Int. J. Surg. 34 (2016), 180–186.
12. [12] Valdebran, M., Elbendary, A., Chaitanya Arudra, S.K., et al. Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma. J. Am. Acad. Dermatol. 75:5 (2016), 1032–1037.
13. [13] Skelton, H.G. III, Smith, K.J., Barrett, T.L., Lupton, G.P., Graham, J.H., HMB-45 staining in benign and malignant melanocytic lesions: a reflection of cellular activation. Am. J. Dermatopathol. 13:6 (1991), 543–550.
14. [14] Gambichler, T., Petig, A.L., Stockfleth, E., Stucker, M., Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma. Clin. Exp. Dermatol. 4:7 (2016), 709–716.
15. [15] Yan, S., Brennick, J.B., False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am. J. Surg. Pathol. 28:5 (2004), 596–600.